Fundraising Fox

Tanja Dowe

Investor

Managing Director at Angelini Ventures

Geneva

About

Tanja Dowe is a Managing Director at Angelini Ventures. She previously served as CEO of the Debiopharm Innovation Fund in Lausanne, Switzerland, where she developed a portfolio of digital health and data-driven R&D companies, and earlier was Managing Partner of the life sciences consulting firm Innomedica Ltd and founder-CEO of the market research agency BioSolutions INT. She holds an MSc in Applied Microbiology and Biochemistry from Helsinki University of Technology (now Aalto University).

Contact· self-published, not guessed

Invests in

Digital HealthHealthtech

Experience

  1. Nobi Smart LightsBoard Membercurrent2025 — present
  2. Noctrix Health, Inc.Board Observercurrent2024 — presentPleasanton, California, United States
  3. Angelini VenturesManaging Directorcurrent2023 — present
  4. ReaktorBoard Member2022 — 2024Helsinki, Finland
  5. VivoSense, Inc.Board Member2022 — 2023Newport Beach, California, United States
  6. NovadiscoveryBoard Member2019 — 2023Lyon, France
  7. Debiopharm International SACEO, Debiopharm Innovation Fund S.A.2017 — 2023Lausanne, Switzerland
  8. Debiopharm International SAHead of Debiopharm Innovation Fund2016 — 2017Lausanne, Switzerland
  9. OncomfortBoard Member2022 — 2023Wavre, Belgium
  10. OncomfortChairwoman of the Board2020 — 2021Wavre, Belgium
  11. VoluntisBoard Observer2020 — 2021Paris, France
  12. Kaiku HealthChairwoman of the Board2019 — 2020Helsinki, Finland
  13. Kaiku HealthBoard Member2018 — 2019
  14. GenePOCChairwoman of the Board2017 — 2019Québec, Quebec, Canada
  15. GenePOCBoard Member2016 — 2017Québec, Quebec, Canada
  16. Living Factories programme - Synthetic Biology for a sustainable BioeconomyMember of the Steering Board2015 — 2016
  17. Innomedica LtdManaging Partner2012 — 2016Helsinki & London, Lund, Tokyo, Zürich
  18. Innomedica LtdManaging Director2009 — 2011Helsinki, Finland
  19. Innomedica LtdVice President, Business Development; Manager, Market Intelligence2002 — 2009Helsinki, Finland
  20. BioSolutions INTEntrepreneur, CEO2000 — 2002Helsinki, Finland & San Diego, USA
  21. TekesIndustry Analyst1999 — 2000Los Angeles
  22. FinproIntern, Assistant to the Trade Commissioner1998Toronto

Skills & more

Biotechnology41Start-ups35Market Intelligence18R&D21Strategy27Lifesciences12Management17Business Development16Strategic Planning8Market Analysis10Commercialization14Product Development6
+12 moreMicrobiologyDrug DevelopmentInternational BusinessInnovation ManagementTechnology TransferPharmaceutical IndustryEntrepreneurshipClinical TrialsLicensingBusiness PlanningBusiness StrategyValuation

Languages English · Finnish · French · German · Swedish · Swiss-German

From Tanja's professional profile.

Colleagues at Angelini Ventures

Frequently asked questions

Who is Tanja Dowe?
Tanja Dowe is a Managing Director at Angelini Ventures. She previously served as CEO of the Debiopharm Innovation Fund in Lausanne, Switzerland, where she developed a portfolio of digital health and data-driven R&D companies, and earlier was Managing Partner of the life sciences consulting firm Innomedica Ltd and founder-CEO of the market research agency BioSolutions INT. She holds an MSc in Applied Microbiology and Biochemistry from Helsinki University of Technology (now Aalto University).
Where does Tanja Dowe work?
Tanja Dowe is Managing Director at Angelini Ventures.
What does Tanja Dowe invest in?
Tanja Dowe invests in Digital Health, Healthtech.
Where did Tanja Dowe go to school?
Tanja Dowe studied at Teknillinen korkeakoulu-Tekniska högskolan (MSc Tech., Major: Applied microbiology; Minors: biochemistry, bioprocess engineering).

Same school

Shared employers